Ampyra Oral Tablet, Extended Release 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Ampyra: Oral tablet, extended release (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

DALFAMPRIDINE (dal FAM pri deen) may help improve walking in patients with multiple sclerosis. This medicine is not a cure.

In-Depth Information

Ampyra 10mg Extended-Release Tablet

NDC: 101440427
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Multiple Sclerosis

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Ampyra 10mg Extended-Release Tablet

Reported Side Effects for Ampyra 10mg Extended-Release Tablet

Convulsions Incidence:
<0.3%*
Severity: SEVERE
Onset: DELAYED
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
12.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More